JMI Hospital Requisite Manufacturing Ltd (JHRML) has announced a capital injection of Tk 11.50 crore into its subsidiary, JMI Specialized Hospital Limited. The funds will be utilized to finalize an ongoing project, procure machinery, and bolster working capital, as per a recent disclosure on the Dhaka Stock Exchange (DSE) website. The investment has been approved by the board to support the expansion and operational needs of the hospital.
JHRML, a leading producer of medical equipment and parts, experienced a 14 percent decrease in net profit to Tk 6.24 crore in the first quarter of 2025. Established in 2008 in partnership with South Korea, the company manufactures a diverse range of products such as IV cannulas, bulk needles, blood transfusion sets, and urine drainage bags. These products are distributed both locally and internationally.
According to the latest data from DSE, as of September 30, 2025, the ownership breakdown of JHRML is as follows: sponsors and directors hold 32.30 percent, institutional investors own 43.05 percent, and public shareholders possess 24.65 percent of the company’s shares.